Monte Rosa Therapeutics Statistics
Total Valuation
GLUE has a market cap or net worth of $262.65 million. The enterprise value is -$17.87 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GLUE has 61.51 million shares outstanding. The number of shares has increased by 47.16% in one year.
| Current Share Class | 61.51M |
| Shares Outstanding | 61.51M |
| Shares Change (YoY) | +47.16% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 58.27% |
| Float | 30.70M |
Valuation Ratios
The trailing PE ratio is 55.11.
| PE Ratio | 55.11 |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| Forward PS | 8.20 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | 8.74 |
| P/OCF Ratio | 7.68 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61, with a Debt / Equity ratio of 0.15.
| Current Ratio | 5.61 |
| Quick Ratio | 5.53 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.53 |
| Debt / FCF | 1.37 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.88% and return on invested capital (ROIC) is -0.52%.
| Return on Equity (ROE) | 2.88% |
| Return on Assets (ROA) | -0.40% |
| Return on Invested Capital (ROIC) | -0.52% |
| Return on Capital Employed (ROCE) | -0.64% |
| Revenue Per Employee | $1.19M |
| Profits Per Employee | $45,918 |
| Employee Count | 134 |
| Asset Turnover | 0.48 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GLUE has paid $3.31 million in taxes.
| Income Tax | 3.31M |
| Effective Tax Rate | 34.97% |
Stock Price Statistics
The stock price has decreased by -12.58% in the last 52 weeks. The beta is 1.52, so GLUE's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -12.58% |
| 50-Day Moving Average | 5.12 |
| 200-Day Moving Average | 6.15 |
| Relative Strength Index (RSI) | 42.23 |
| Average Volume (20 Days) | 521,882 |
Short Selling Information
The latest short interest is 7.88 million, so 12.81% of the outstanding shares have been sold short.
| Short Interest | 7.88M |
| Short Previous Month | 7.53M |
| Short % of Shares Out | 12.81% |
| Short % of Float | 25.66% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, GLUE had revenue of $159.49 million and earned $6.15 million in profits. Earnings per share was $0.08.
| Revenue | 159.49M |
| Gross Profit | 46.62M |
| Operating Income | -2.13M |
| Pretax Income | -129.93M |
| Net Income | 6.15M |
| EBITDA | 6.14M |
| EBIT | -2.13M |
| Earnings Per Share (EPS) | $0.08 |
Full Income StatementBalance Sheet
The company has $326.07 million in cash and $41.86 million in debt, giving a net cash position of $284.21 million or $4.62 per share.
| Cash & Cash Equivalents | 326.07M |
| Total Debt | 41.86M |
| Net Cash | 284.21M |
| Net Cash Per Share | $4.62 |
| Equity (Book Value) | 275.16M |
| Book Value Per Share | 4.47 |
| Working Capital | 273.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $34.67 million and capital expenditures -$4.19 million, giving a free cash flow of $30.48 million.
| Operating Cash Flow | 34.67M |
| Capital Expenditures | -4.19M |
| Free Cash Flow | 30.48M |
| FCF Per Share | $0.50 |
Full Cash Flow StatementMargins
Gross margin is 29.23%, with operating and profit margins of -1.33% and 3.86%.
| Gross Margin | 29.23% |
| Operating Margin | -1.33% |
| Pretax Margin | 5.93% |
| Profit Margin | 3.86% |
| EBITDA Margin | 3.85% |
| EBIT Margin | -1.33% |
| FCF Margin | 19.11% |
Dividends & Yields
GLUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.16% |
| Shareholder Yield | -47.16% |
| Earnings Yield | 2.31% |
| FCF Yield | 11.44% |
Analyst Forecast
The average price target for GLUE is $14.33, which is 235.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.33 |
| Price Target Difference | 235.60% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 1.09% |
| EPS Growth Forecast (5Y) | 12.89% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GLUE has an Altman Z-Score of 1.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.64 |
| Piotroski F-Score | 6 |